Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
3.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.1K
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

An analysis of succinate dehydrogenase B in pleural mesothelioma.

Discover oncology·2026
Same author

FKBP52 in cancer biology and therapy: molecular mechanisms, signalling networks, and drug targeting of the FKBP protein family.

Biochemical pharmacology·2026
Same author

Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Structure-activity relationship of steroidal-nitroxide hybrids: Dual-modulators of glucocorticoid receptor signalling and cellular redox state.

European journal of medicinal chemistry·2026
Same author

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Redox biology·2026

Related Experiment Video

Updated: May 4, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.1K

Genome stability pathways in head and neck cancers.

Glenn Jenkins1, Kenneth J O'Byrne2, Benedict Panizza3

  • 1University of Queensland, Brisbane, QLD, Australia ; Cancer and Ageing Research Program, Institute of Health and Biomedical Innovation at the Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.

International Journal of Genomics
|December 24, 2013
PubMed
Summary

Genomic instability drives head and neck cancers. DNA repair pathways are key to understanding cancer risk, progression, and treatment response in squamous cell carcinoma of the head and neck (HNSCC).

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.2K
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.0K

Related Experiment Videos

Last Updated: May 4, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.1K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.2K
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

6.0K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Genomic instability is fundamental to cancer development, invasion, metastasis, and treatment response.
  • Squamous cell carcinoma of the head and neck (HNSCC) exhibits diverse genomic stability profiles influencing patient outcomes.
  • Defective DNA repair contributes to chromosomal abnormalities and gene expression changes, hallmarks of cancer progression.

Purpose of the Study:

  • To review recent advancements in understanding genomic stability within HNSCC.
  • To emphasize the role of DNA repair pathways in HNSCC pathogenesis and clinical behavior.
  • To explore how genomic stability influences HNSCC risk, treatment response, and prognosis.

Main Methods:

  • Review of current literature on genomic stability and DNA repair in HNSCC.
  • Analysis of how etiological factors (HPV, tobacco, alcohol) impact HNSCC through genomic stability.
  • Examination of potential biomarkers for prognosis and treatment prediction.

Main Results:

  • HNSCC displays distinct genomic stability profiles correlating with risk, treatment response, and outcomes.
  • Genetic variations in DNA repair genes are linked to increased cancer risk.
  • Etiological factors induce varied HNSCC behaviors due to differences in genomic stability.

Conclusions:

  • Genomic stability and DNA repair pathways are critical determinants of HNSCC behavior.
  • Targeted therapies and biomarkers related to DNA repair offer promising avenues for HNSCC management.
  • Further development of genomic stability models will enhance understanding and treatment of HNSCC.